ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Sep 19, 2013
Insider Transaction Report
Form 4
Ozeroff Christopher David
EVP & General Counsel
Transactions
- Award
Common Stock
2013-09-17$1.38/sh+75,000$103,500→ 92,537 total - Award
Stock Option (right to buy)
2013-09-17+42,642→ 42,642 totalExercise: $1.38Exp: 2023-09-17→ Common Stock (42,642 underlying)
Footnotes (2)
- [F1]Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2013 Equity Incentive Plan (the "Plan"). The RSUs vest in three equal annual installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
- [F2]Grant to the Reporting Person of a stock option under the 2013 Equity Incentive Plan, vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.